期刊文献+

A型肉毒类毒素聚乳酸微球制备及酶联免疫吸附测定方法

Preparative conditions for polylactide microspheres containing botulinum A-type toxoid and the establishment of detection
下载PDF
导出
摘要 目的以A型肉毒类毒素为模型药,探讨聚乳酸用于包裹生物大分子的可能性。方法采用水-油-水复乳溶剂挥发法制备微球,并测定粒径和包封率,用间接酶联免疫吸附测定法检测免疫鼠血清中的抗体水平。结果获得了60%以上的包封率,微球粒径可控制在30~200μm,微球在体内缓慢释放诱导抗体产生。结论采用水-油-水复乳溶剂挥发法制备微球,成功地制备了A型肉毒类毒素免疫微球,可用于运载生物大分子。 Objective To explore the possibility of entrapping biopharmaceutical macromolecular by preparing polylactide microspheres containing botulinum A-type toxoid as model drug. Methods The vaccine was entrapped by employing a water-in-oil-in-water emulsion solvent evaporation technique.The effects of process parameters on particle size and protein entrapment were investigated.The dynamic antibody level in serum was monitored by indirect enzyme-link immunosorbent assay to evaluate the slow-release.Results It was found that microspheres with loading efficiency up to 60%could be produced and 30-200μm in diameter could be controlled. The microspheres induced better antibody response and had slow-release effect.Conclusion The preparation of polylactide microspheres with an entrapped vaccine botulinum A-type toxoid is studied.The polylactide microspheres made by water-in-oil-in-water emulsion solvent evaporation technique can be used as carriers for delivering biopharmaceutical macrornolecular.
出处 《兰州大学学报(医学版)》 CAS 2010年第4期52-54,58,共4页 Journal of Lanzhou University(Medical Sciences)
关键词 A型肉毒类毒素 聚乳酸 微球 酶联免疫吸附测定法 botulinum A-type toxoid polylactide microspheres enzyme-link immunosorbent assay
  • 相关文献

参考文献10

  • 1JAGANATHAN K S,RAO Y U B,PARAMJIT S,et al.Development of a single does tetanus toxoid formulation based on polymeric microspheres:a comparative study of poly(D,L-lactic-co-glycolic acid)versus chitosan microspheres[J].International Journal of Pharmaceutics,2005,294(1):23-32.
  • 2PEYRE M,AUDRAN R,ESTEVEZ F,et al.Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions[J].Control Release,2004,99(3):345-355.
  • 3MOREFIELD G L,SOKOLOVSAK A,JIANG D,et al.Role of aluminium-containing adjuvants in antigen internalization by dendritic cells in vitro[J].Vaccine,2005,23(13):1588-1593.
  • 4HE YING,WEI Shu-li.Study on preparative conditions for polylactide microspheres containing tetanus toxoid[J].Chinese Pharmaceutical Journal Beijing,2001,36(1):391-393.
  • 5HAROLD F,STILLS J.Adjuvants and antibody production:dispelling the myths associated with freunds complete and other adjuvants[J].ILAR Journal,2005,46(3):280-293.
  • 6ZAHAROFF D A,ROGERS C J,HANCE K W,et al.Chitosan solution enhances both humoral and cellmediated immune responses to subcutaneous vaccination[J].Vaccine,2007,25(11):2085-2094.
  • 7AKBUGA J,OZBAS T S,ERDOGAN N.Plasmid-DNA loaded chitosan microspheres for in vitro IL-2expression[J].Eur J Pharm Biopharm,2004,58(3):501-507.
  • 8YUAN Y,CHESNUTT B M,UTTURKAR G,et al.The effect of cross-linking of chitosan microspheres with genipin on protein release[J].Carbohydr Polym,2007,68(3):561-567.
  • 9KANG Mi-lan,CHO Chong-su,YOU Han-sang,et al.Application of chitosan microspheres as carriers of LH-RH analogue TX46[J].React Funct Polym,2009,27(6):857-865.
  • 10WANG Lian-yan,Gu Yong-hong,Su Zhi-guo,et al.Preparation and improvement of release behavior of chitosan microspheres containing insulin[J].Int J Pharm,2006,311(1):187-195.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部